Evidence map›Paper›PMID 42326332›Full record

ArticleFrontiers in oncology2026

Development and validation of a machine learning-based risk prediction model for cancer-related fatigue in ovarian cancer patients.

Ru Feng, Zexuan Fan, Yuanyuan Pang, Qifan Ding, Qian Yue, Siqi Wei

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ru FengSchool of Nursing, Lanzhou University, Lanzhou, Gansu, China.
Zexuan FanSchool of Nursing, Lanzhou University, Lanzhou, Gansu, China.
Yuanyuan PangSchool of Nursing, Lanzhou University, Lanzhou, Gansu, China.
Qifan DingSchool of Nursing, Lanzhou University, Lanzhou, Gansu, China.
Qian YueSchool of Nursing, Lanzhou University, Lanzhou, Gansu, China.
Siqi WeiSchool of Nursing, Lanzhou University, Lanzhou, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer-related fatigue (CRF) substantially compromises quality of life in ovarian cancer, yet reliable early detection tools remain inadequate. This study sought to develop a machine learning-based predictive model for CRF risk. Methods: We consecutively recruited 407 ovarian cancer patients from three tertiary hospitals in Lanzhou, China (October 2024-August 2025). Data were randomly partitioned into training (70%) and testing (30%) sets. Least Absolute Shrinkage and Selection Operator (LASSO) regression was applied for feature selection. Seven machine learning algorithms were developed, with the optimal model selected through comparative evaluation and subjected to SHAP interpretability analysis. Results: CRF prevalence was 39.6%. The Support Vector Machine (SVM) demonstrated superior overall predictive performance: AUC of 0.884, accuracy of 0.829, sensitivity of 0.816, specificity of 0.838, and F1 score of 0.792; good calibration (Brier score = 0.132); and decision curve analysis showed the highest net benefit across a wide range of threshold probabilities (0.05-0.85), indicating strong clinical utility. SHAP analysis identified serum calcium level, anxiety-depression status, red blood cell count, education level, cancer stage, medical payment method, and marital status as top predictive features. Conclusions: The SVM model exhibits robust predictive efficacy and good clinical utility, serving as a valuable tool for CRF risk stratification in ovarian cancer care. Early identification of high-risk patients enables targeted interventions to improve outcomes.

Indexed as

cancer-related fatiguemachine learningovarian cancerrisk prediction modelsupport vector machine

Identifiers

PMID42326332
PMCPMC13275719

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.